CEDAR is proud to be part of the International Alliance for Cancer Early Detection, or ACED, a new $70 million partnership with four other world-leading centers for cancer early detection research: the Canary Center at Stanford for Cancer Early Detection, the University of Cambridge, University College London and the University of Manchester. For decades, despite offering tremendous potential for transformational improvements in patient outcomes, progress in cancer early detection research has been hamstrung by unique scientific and clinical challenges. By uniting some of the best scientific talent from across the U.S. and the U.K., the Alliance aims to accelerate and revolutionize research in this profoundly important field, leading to improved cancer diagnosis methods to meaningfully benefit people struggling with cancer.
Want to learn more?
You can learn more about ACED, including information on its aims, scientific strategy, training and development programs, and funding opportunities, at the Alliance's website. We'll be introducing new opportunities to work with the Alliance as it develops.
The ACED Welcome Packet provides more helpful information about navigating ACED at OHSU, including how to get involved, how to initiate research projects, and how to become a member.
Contact CEDAR's Erin Watson with any questions concerning ACED.